Cargando…
Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model
The persistence of leukemic stem cells (LSCs) represents a problem in the therapy of chronic myeloid leukemia (CML). Hence, it is of utmost importance to explore the underlying mechanisms to develop new therapeutic approaches to cure CML. Using the genetically engineered ScltTA/TRE-BCR::ABL1 mouse m...
Autores principales: | Langhammer, Melanie, Schöpf, Julia, Jaquet, Timo, Horn, Katharina, Angel, Moritz, Spohr, Corinna, Christen, Daniel, Uhl, Franziska Maria, Maié, Tiago, Jacobi, Henrike, Feyerabend, Thorsten B., Huber, Julia, Panning, Marcus, Sitaru, Cassian, Costa, Ivan, Zeiser, Robert, Aumann, Konrad, Becker, Heiko, Braunschweig, Till, Koschmieder, Steffen, Shoumariyeh, Khalid, Huber, Michael, Schemionek-Reinders, Mirle, Brummer, Tilman, Halbach, Sebastian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317838/ https://www.ncbi.nlm.nih.gov/pubmed/37161070 http://dx.doi.org/10.1038/s41375-023-01916-x |
Ejemplares similares
-
P653: CML LONG-TERM LEUKEMIC STEM CELL PERSISTENCE IS INFLUENCED BY MYELOFIBROSIS AT DIAGNOSIS
por: Jacobi, Henrike, et al.
Publicado: (2023) -
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
por: Jacobi, Henrike, et al.
Publicado: (2023) -
The SCLtTAxBCR-ABL transgenic mouse model closely reflects the differential effects of dasatinib on normal and malignant hematopoiesis in chronic phase-CML patients
por: Schubert, Claudia, et al.
Publicado: (2017) -
Gab2 is Essential for Transformation by FLT3-ITD in Acute Myeloid Leukemia
por: Sies, Katharina, et al.
Publicado: (2019) -
Intracellular Retention of ABL Kinase Inhibitors Determines Commitment to Apoptosis in CML Cells
por: Lipka, Daniel B., et al.
Publicado: (2012)